The Santé Cannabis Model of Care
Setting the Global Standard for Medical Cannabis Clinical Practice Leading Patient Service, Clinical Care Standards and Clinical Research Data Collection in Cannabinoid-Based Medicines By Erin…
Professional Training and Education
Conference on Cannabinoid-based Medicines: their integration into Quebec’s clinical practice
On March 24th, 2021 we were pleased to present our fourth annual medical cannabis forum series, now called the “Conference on cannabinoid-based medicines” – this…
Substance Use Disorder: Treating Withdrawal Symptoms with Medical Cannabis
Using medical cannabis to treat … a cannabis use disorder? While the concept might seem counterintuitive, preclinical research and evidence from clinical trials suggest targeting…
Multiple Sclerosis and Nabiximols: What to Consider When Treating Spasticity
Multiple sclerosis is a progressive, chronic neurodegenerative disease that impacts over 80,000 people in Canada, and more than 2.3 million people globally. In August 2010, nabiximols…
Medical Cannabis and Fibromyalgia: A Comprehensive Approach to Improving Quality of Life
The limited success of conventional treatments for fibromyalgia has made medical cannabis an increasingly sought-after option for patients and their healthcare teams who are struggling…
Medical Cannabis and Anxiety: Addressing Misconceptions
Millions of people in Canada and around the world have had their lives upended by the ongoing public health crisis. For many, the impact of…
IBS and Medical Cannabis: The State of Research and Clinical Practice
Irritable Bowel Syndrome, or IBS, is the most common gastro-intestinal diagnosis. It is also one of the most difficult to treat, often leaving patients and…
Santé Cannabis Helping Doctors in Thailand
Santé Cannabis research director Dr. Antonio Vigano travelled to Thailand earlier this month to conduct a presentation and training workshop at a university affiliated teaching…